These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 1522442

  • 21. International Cooperation on Harmonisation of Technical requirements for Approval of Veterinary Medicinal Products (VICH); final guidance on " Safety studies for veterinary drug residues in human food: reproduction toxicity testing" (VICH GL22); availability. Notice.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 Jan 04; 67(3):603-5. PubMed ID: 12365425
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. IV. Fiber shedding properties of depth filter media for sterile filtration.
    Dwyer JL.
    Bull Parenter Drug Assoc; 1975 Jan 04; 29(5):227-37. PubMed ID: 1182333
    [No Abstract] [Full Text] [Related]

  • 25. FDA regulation of veterinary prescription drugs.
    Stefan GE, Beaulieu AJ, Ballitch EJ.
    J Am Vet Med Assoc; 1986 Sep 01; 189(5):513-7. PubMed ID: 3759623
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. PDA response. FDA advance notice of proposed rulemaking on electronic identification/signatures. Parenteral Drug Association.
    J Parenter Sci Technol; 1993 Sep 01; 47(1):4-8. PubMed ID: 8445499
    [No Abstract] [Full Text] [Related]

  • 28. Criteria for extra-label drug use debated at FDA Advisory Committee meeting.
    Raef TA.
    J Am Vet Med Assoc; 1995 Jul 01; 207(1):10-1. PubMed ID: 7601683
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. FDA backs legislation to restrict antimicrobial use.
    Cima G.
    J Am Vet Med Assoc; 2009 Sep 01; 235(5):493-5. PubMed ID: 19731457
    [No Abstract] [Full Text] [Related]

  • 32. FDA extra-label use policy: 1992 revisions.
    Guest GB, Solomon SM.
    J Am Vet Med Assoc; 1993 May 15; 202(10):1620-3;discussion 1626-31. PubMed ID: 8514568
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Glutaraldehyde sterilants: FDA vs. APIC soaking times.
    Healthc Hazard Mater Manage; 1995 Jun 15; 8(9):1-2. PubMed ID: 10143314
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Safety monitoring of drugs granted exclusivity under the Best Pharmaceuticals for Children Act: what the FDA has learned.
    Mathis LL, Iyasu S.
    Clin Pharmacol Ther; 2007 Aug 15; 82(2):133-4. PubMed ID: 17632537
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.